TOPLINE: Semaglutide does not appear to increase the risk for postoperative pneumonia in diabetic patients undergoing elective surgery, a new study found. METHODOLOGY: Researchers conducted a...
TOPLINE: An artificial intelligence–based model that incorporates polygenic and multi-image risk scores with key demographic variables effectively identifies individuals at a high risk for type 2...
LISBON — Patients with acute heart failure on the sodium-glucose cotransporter 2 (SGLT2) inhibitor dapagliflozin who received diuretic therapy experienced rapid decongestion with shorter hospital stays,...
TOPLINE: Long-term exposure to fine particulate matter is associated with higher fasting blood glucose (FBG) levels and an increased type 2 diabetes risk, significantly contributing to...
TOPLINE: A diet rich in green, leafy, cruciferous, and colorful vegetables may improve glucose tolerance and insulin sensitivity, whereas a high intake of potato fries or...
STOCKHOLM — In the treatment of type 2 diabetes, sodium-glucose cotransporter 2 (SGLT2) inhibitors and glucagon-like peptide 1 receptor agonists (GLP-1 RAs) show independent benefits that...
Insurance companies frequently deny insurance coverage of glucagon-like peptide-1 (GLP-1) receptor agonists for adolescents, according to a new analysis. For those whose GLP-1 prescriptions were covered,...
PARIS — For the first time, there is compelling evidence that the degree of poor glycemic control in patients with type 2 diabetes is a relative...
TOPLINE: A low physical activity level combined with type 2 diabetes (T2D), whereas only moderate physical activity benefits those sedentary for ≥ 6 hours each day....